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LensThe small heat shock protein αA-crystallin is a structural protein in the ocular lens. In addition, recent studies
have also revealed that it is a molecular chaperone, an autokinase and a strong anti-apoptotic regulator. Besides
its lenticular distribution, a previous study demonstrates that a detectable level ofαA-crystallin is found in other
tissues including thymus and spleen. In the present study, we have re-examined the distribution ofαA-crystallin
in various normal human and mouse tissues and found that the normal pancreas expresses a moderate level of
αA-crystallin. Moreover, αA-crystallin is found signiﬁcantly downregulated in 60 cases of pancreatic carcinoma
of different types than it is in 11 normal humanpancreas samples. In addition,we demonstrate thatαA-crystallin
can enhance the activity of the activating protein-1 (AP-1) through modulating the function of the MAP kinase,
and also upregulates components of TGFβ pathway. Finally, expression ofαA-crystallin in a pancreatic cancer cell
line, MiaPaCa, results in retarded cell migration. Together, these results suggest that αA-crystallin seems to
negatively regulate pancreatic carcinogenesis.stry and Molecular Biology,
ka Medical Center, Omaha, NE
559 6650.
.
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Heat shock proteins (HSPs) are implicated in multiple cellular
functions including signaling transduction, protein degradation,
survival promotion, exocytosis and endocytosis [1–5]. Recent studies
have revealed that HSPs also play an important role in tumorigenesis
[6–8]. The lens structural proteins, αA- and αB-crystallins are
characterized as HSPs [9]. Besides their robust expression in
mammalian lens [10,11], the two α-crystallins are also expressed in
non-lenticular tissues. αB-crystallin is signiﬁcantly expressed in the
retina, muscle, heart and brain, and acts to prevent neural degrada-
tion, and heart failure, but promote carcinogenesis [4,5,12–15]. αA-
crystallin is also expressed in some non-lenticular tissues, such as the
retina, spleen and thymus [16]. However, the function of non-
lenticular αA-crystallin remains unknown.Pancreatic cancer in human poses clinical challenges in diagnosis
and treatment [17,18]. Among the various types of pancreatic
malignancies, pancreatic duct adenocarcinoma is dominant and in
addition, the mucinous adenocarcinoma, islet adenocarcinoma and
acinic cell carcinoma are also observed with less frequency of
occurrence [19,20]. At the molecular level, development of pancreatic
malignancies is associated with canonical oncogenes and tumor
suppressor genes, such as Ki-Ras, p16, p53, Smad4 and BRCA2, which
are involved in several cross-talking cellular signaling pathways
including TGFβ/SMAD, PI3K/AKT, and MAPK pathways [20–22].
In the present study, we present evidence to show thatαA-crystallin
is expressed in the normal human and mouse pancreas at a moderate
level. Moreover, analysis of αA-crystallin in the tissue samples from
normal human pancreas and 60 cases of pancreatic carcinoma reveals
signiﬁcantdifference.αA-crystallin is downregulatedmore than10-fold
in the pancreatic carcinoma of various types than that in normal
pancreas. To explore the possible role of αA-crystallin in pancreatic
carcinoma, we demonstrate here for the ﬁrst time that αA-crystallin
positively regulates the DNA binding and transactivity of the activating
protein-1 (AP-1). This upregulation of AP-1 activity is derived from
changed MAPK activity, which can positively regulate c-Jun and c-Fos.
Moreover, expression of αA-crystallin in pancreatic cells enhances
Table 1
Oligos used to detect expression of the related genes.
Gene Primers
β-actin 5′-GTGGGGCGCCCCAGGCACCA-3′
5′-CTCCTTAATGTCACGCACGATTTC-3′
αA-crystallin 5′-GGCTGTTCGACCAGTTTTTC-3′
5′-CAGACAGGGAGCAAGAGAGG-3′
αB-crystallin 5′-TTCTTCGGAGAGCACCTGTT-3′
5′-GCCAGAGACCTGTTTCCTTG-3′
TGFβ 5′-GGGACTATCCACCTGCAAGA-3′
5′-CGGAGCTCTGATGTGTTGAA-3′
TGFβR1 5′-GAGCATGGATCCCTTTTTGA-3′
5′-AACATCGTCGAGCAATTTCC-3′
TGFβR2 5′-GGGGAAACAATACTGGCTGA-3′
5′-TCACACAGGCAGCAGGTTAG-3′
TGFβR3 5′-CAGTCCACATCCACCACAAG-3′
5′-ACACACCCTTCTGCTGCTTT-3′
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pancreatic cancer cells leads to retarded cell migration. Together,
these results suggest that αA-crystallin appears to suppress pancreatic
carcinogenesis.
2. Materials and methods
2.1. Reagents and antibodies
Anti-αA/B-crystallin antibodies were described before [23]. ERK2
kinase assay kit, and anti-phosphorylated Elk antibody were pur-
chased from Cell Signaling, Inc. Anti-c-Jun antibody was a kind gift
from Dr. Tom Curran's Laboratory. Anti-c-Fos, anti-Lamin B, and anti-
β-actin antibodies were purchased from Santa Cruz Biotechnology.
Human normal pancreas and pancreatic carcinoma tissue samples
were obtained from US Biomax, Inc.
2.2. Immunohistochemistry analysis ofαA-crystallin,measure ofﬂuorescence
intensity and HE staining
Immunohistochemistry analysis was conducted as recently de-
scribed [24]. Brieﬂy, the sections were rehydrated in graded alcohols,
heated up to boiling for 5 min in citrate buffer at pH6. The sectionswere
washed three times with PBS. For non-speciﬁc blocking, each section
was incubated in 500 μl of 5% normal goat serum (Sigma-Aldrich, CA) in
PBS for 1 h at room temperature and then incubated overnight in 400 μl
of diluted anti-αA-crystallin antibody (1:100) in a humidiﬁed chamber
at 4 °C. The sections were then washed with PBS three times (5 min
each) followed by incubation with 400 μl of FITC-linked secondary
antibody and DAPI (Vector Laboratories, CA) in blocking solution for 1 h
in the absence of visible light. After incubation, sections were washed
with PBS at room temperature 6 times (5 min each) and then observed
under a Carl Zeiss Laser Scanning Confocal microscope. For negative
controls, the sections were treated in the same way except that the
primary antibody was replaced with normal serum IgG.
A quantitative measure of ﬂuorescence intensity was conducted
using confocal microscopy for assessment of the level of αA-crystallin
expression. During analysis of the obtained results, the designated
values of 0 to 10, 10 to 100, 100 to 1000 andmore than 1000 represent
negative background, weak, moderate and strong expression of αA-
crystallin, respectively. The same immunohistochemical quantitative
system was used for tissue microarray analysis by others [25]. Each
core was measured individually. If more than one core was evaluated
from each tissue the mean intensity and standard deviation were
calculated and shown as mean±SD.
For histology analysis, hematoxylin and eosin (HE) staining was
conducted as recently described [26].
2.3. Cell culture and cell fraction extraction
The preparation of the pEGFP-C3 and pEGFP-C3-αA/αB-crystallin
expression constructs, and establishment of stable transfected cell
lines were conducted as previously described [23,24]. The pEGFP-
αTN4-1, pEGFP-αA-αTN4-1, pEGFP-αB-αTN4-1, pEGFP-MiaPaCa,
pEGFP-αA-MiaPaCa and pEGFP-αB-MiaPaCa stable clones were
grown in Dulbecco's Modiﬁed Eagle's Minimal Essential Medium
(DMEM) containing 10% fetal bovine serum, 50 U/ml penicillin and
streptomycin and 400 μg/ml neomycin as described before [23,24].
All cells were kept at 37 °C and 5% CO2 gas phase. Cell fractions were
extracted by differential sucrose gradient as previously described [23].
The cytoplasmic and nuclear extracts of vector (pEGFP)-, αA-crystal-
lin (pEGFP-αA)- or αB-crystallin (pEGFP-αB)-transfected cells were
used for Western blot analysis. The nuclear extracts from parent,
vector (pEGFP)-, αA-crystallin (pEGFP-αA)- or αB-crystallin (pEGFP-
αB)-transfected cells were used for gel mobility shifting assays.2.4. Reverse transcription-linked polymerase chain reaction (RT-PCR)
Total RNA samples were extracted from αA-crystallin-transfected
cells (pEGFP-αA-MiaPaCa), αB-crystallin-transfected cells (pEGFP-
αB-MiaPaCa), vector-transfected cells (pEGFP-MiaPaCa) and control
parent pancreatic cancer cells (MiaPaCa) using TRIZOL reagent. Five µg
of total RNA from each sample was used for cDNA synthesis. Several
components of TGFβ signaling pathway were examined by RT-PCR
using speciﬁc primer pairs listed in Table 1. The PCR reaction is: 94 °C
for 5 min; 94 °C for 30 s, 55 °C for 30 s, and 72 °C for 40 s, in 30 cycles;
72 °C for 5 min; kept at 4 °C. The PCR products were examined by
agarose gel electrophoresis and visualized under UV illumination.2.5. Gel mobility shifting assay
Gel mobility shifting assays were conducted as previously described
[27–29]. The following oligos were used: 5′-GTCCTTCATTACGTCACG-
CATAG-3′ for conserved AP-1 binding site, 5′-GTCCTTCATTCATTCACG-
CATAG-3′ for mutated AP-1 binding site; 20 μg of nuclear extracts or
cytoplasmic extracts prepared from the pEGFP-αTN4-1, pEGFP-αA-
αTN4-1, pEGFP-MiaPaCa, and pEGFP-αA-MiaPaCa cells was incubated
with 1×105 cpm of 32P-labeled double-stranded synthetic oligonucleo-
tides for 30 min at 37 °C in binding shifting buffer [27–29]. For
competition experiments, 50-fold of the non-labeled wild type or
mutant double-stranded synthetic oligonucleotides was pre-incubated
with the nuclear extracts for 30 min before the labeled probewas added
into the reaction. For the pre-cleared experiments, 20 μg of nuclear
extract prepared from pEGFP-αTN4-1, pEGFP-αA-αTN4-1, pEGFP-
MiaPaCa, and pEGFP-αA-MiaPaCa cells was pre-incubated with 10 µg
antibody against c-Jun or/and c-Fos for 1 h on ice, then mixed with
protein A/G agarose and rotated for additional 1 h at 4 °C, and then the
supernatant was recovered for incubation with 1×105 cpm of 32P-
labeled double-stranded synthetic AP-1 oligonucleotides for 30 min
at 37 °C in a binding shifting buffer. After the binding reactions,
the mixtures were loaded onto 6% native PAGE and detected by
autoradiography.2.6. Kinase activity assay
Substrate Elk protein was incubated with different doses of ERK2
kinase, 0.1, 1, 5 or 10 ng ormock kinase, GSK3β in the kinase buffer for
30 min at 37 °C in the presence of ATP. For the effect of αA-crystallin
on ERK kinase, differential concentrations (0, 1 and 10 µg) of puriﬁed
bovine αA-crystallin were added to the kinase assay reactions. After
reaction, the mixtures were loaded to SDS-PAGE and detected by
Western blot analysis using anti-phosphorylated-Elk antibody.
623M. Deng et al. / Biochimica et Biophysica Acta 1802 (2010) 621–6312.7. Western blot analysis
Preparation of total proteins from mouse tissues and various
transfected cells and Western blot analysis of different protein
samples were conducted as previously described [30–32].
2.8. Wound healing assay
The three types of stable clones of pEGFP-MiaPaCa, pEGFP-αA-
MiaPaCa and pEGFP-αB-MiaPaCa cells were seeded in 6-well plates
and cultured until 100% conﬂuent. A straight scratch was made by
using a 1 ml blue pipette tip to simulate the wound in each well. After
PBS washing for 2 times, new DMEM medium was added for a
continuous growth of another 48 h. The wound healing process was
recorded daily using the Leica Inverted Phase Contrast Fluorescence
Microscopy with a 10× objective.
2.9. Statistical analysis
The Student t-test was used to compare the medians of two
unpaired groups. pb0.05 was considered signiﬁcant [31].
3. Results
3.1. Expression of αA-crystallin in human non-lenticular tissues
Recent studies have shown that αB-crystallin is implicated in
promotion of carcinogenesis [6,15,33]. Whether αA-crystallin has
similar functions remains to be explored. For this reason, we have re-
examined the tissue-speciﬁc expression of αA-crystallin in human
non-lenticular tissues using immunohistochemistry analysis of
human multi-organ tissue array samples and confocal microscope
measurement of the relative ﬂuorescence density derived from
immunohistochemistry staining. As shown in Fig. 1A, a strong
lenticular expression of αA-crystallin in the developing mouse eye
was observed, which is consistent with a previously reported result
[10]. In addition, we observed a moderate level of αA-crystallin
expression in human pancreas and to a less degree, in human liver
(Fig. 1A). Similar pancreatic level of αA-crystallin was observed in 7
out of 11 human samples examined (Fig. 1B). In pancreas, αA-
crystallin was speciﬁcally expressed in islets, acinus and interlobular
tubes (Fig. 1A). In other non-lenticular ocular tissues, αA-crystallin
was also expressed at a moderate level in the retina and ciliary
processes (data not shown). The relative mean values of ﬂuorescence
intensities in various non-lenticular tissues were measured with
confocal microscope coupled with related software and were
presented in Fig. 1B.
3.2. Expression of αA-crystallin in mouse tissues
To validate the observed results of αA-crystallin expression in
human samples, we next dissected 10 different tissues from adult
mouse: lens, heart, thymus, kidney, brain, spleen, pancreas, lung, liver
and testis, and analyzed the expression level of αA-crystallin in these
tissues. As shown in the top panel of Fig. 2, Western blot analysis
revealed that besides its robust expression in the ocular lens (lane 1
contains only 0.5 μg protein, the rest of the lanes 100 μg proteins),αA-
crystallin was detected in the thymus and pancreas at a relatively
strong level, then to a less degree in the brain. The αA-crystallin level
in the heart, kidney, spleen and liver was much lower than that in the
thymus and pancreas. Finally, a trace of αA-crystallin was also
observed in testis. No αA-crystallin was detected in the lung. As a
comparison, we also examined the tissue distribution of αB-crystallin
in mouse. Besides the strongest expression in lens, αB-crystallin was
highly expressed in the heart, thymus and brain, and moderately
expressed in the kidney and lung. However, different from the tissue-speciﬁc expression patterns of αA-crystallin, αB-crystallin was barely
detectable in the pancreas and spleen, and absent in the liver and
testis examined. Thus, our results conﬁrm that the pancreas expresses
a moderate level of αA-crystallin. In addition, we also show that
several other non-lenticular tissues also express a low level of αA-
crystallin. These results are slightly different from the pattern of αA-
crystallin detected in different tissues from rat [16,34].
3.3. Downregulation of αA-crystallin in pancreatic tumors
Since both Hsp27 andαB-crystallin are implicated in carcinogenesis
[6–8,15,33,36,37], we reason that αA-crystallin may be also involved in
regulation of carcinogenesis. To test this possibility, we compared the
expression pattern ofαA-crystallin in human normal pancreatic tissues
and various types of pancreatic carcinoma using the tissue array
samples. As shown in Fig. 3A, the expression of αA-crystallin in human
pancreatic cancer tissues was lower than that in human normal
pancreas. Among the 11 normal pancreas samples examined, 7 samples
displayed moderate expression level of αA-crystallin (normal pancreas
A in Fig. 3A) and4 samples relativelyweak expression (normal pancreas
B in Fig. 3A). In contrast, among the 60 cases of pancreatic cancer
samples, 4 had weak expression of αA-crystallin signal (shown as
pancreatic cancer #A of Fig. 3A), 17 displayed barely detectable αA-
crystallin signal and the remaining 39 samples displayed no detectable
signals (shown as pancreatic cancer #B of Fig. 3A).
To further characterize the expression of αA-crystallin in different
human pancreatic cancer, we divided the pancreatic cancer samples
into 4 different types: duct adenocarcinoma (n=48), mucinous
adenocarcinoma (n=3), islet adenocarcinoma (n=6) and acinic cell
carcinoma (n=3). The ﬂuorescence signal in each individual sample
and the statistic data with the mean value of ﬂuorescence intensity of
αA-crystallin expression in each type of pancreatic carcinoma were
presented in Fig. 3B. The expression level of each normal pancreas and
the statistical data derived from the normal pancreas were also
included for comparison (Fig. 3B). Together, our results reveal that
αA-crystallin is signiﬁcantly downregulated in human pancreatic
carcinoma compared with normal pancreas.
3.4. Expression of αA-crystallin in MiaPaCa cells upregulates expression
of c-Jun and c-Fos
It is well established that the transcriptional factor complex,
activating protein-1 (AP-1) plays a signiﬁcant role in tumorigenesis
[38–42]. AP-1 is either a homodimer containing two Jun family
members (c-Jun, Jun-B or Jun D) or a heterodimer containing one
member from the Jun family and another from the Fos family (C-Fos,
Fra-1 and Fra-2) [38,43]. To explore the possible function of αA-
crystallin in human pancreatic cancer, we overexpressed αA-crystal-
lin in both pancreatic cancer cells, MiaPaCa and non-cancer cells,
αTN4-1, a SV40 large-T-transformed mouse lens epithelial cell line
expressing very little endogenous αA-crystallin. Then, we examined
the AP-1 expression and activity in these transfected cells. As shown
in Fig. 4, expression and phosphorylation of c-Jun were signiﬁcantly
upregulated in the nucleus of the MiaPaCa cells expressing αA-
crystallin than in the nucleus of the vector-transfected cells,
expression of c-Fos was also upregulated, though to a much less
degree, in both nucleus and cytoplasm of theMiaPaCa cells expressing
αA-crystallin than in the same fractions of the vector-transfected
cells. Similar results were also obtained in the nucleus of the αTN4-1
cells expressing αA-crystallin (Supplementary Fig. 1).
3.5. Expression of αA-crystallin in MiaPaCa cells upregulates AP-1 activity
To determinewhether the upregulated c-Jun and c-Fos actually led
to increased AP-1 activity, we ﬁrst conducted DNA binding assays
using the oligos containing either the conserved AP-1 binding site
Fig. 1. Expression of αA-crystallin in human normal tissues. (A) Immunohistochemistry of αA-crystallin in the human lens, pancreas, liver, kidney, brain, heart, lung, esophagus,
testis, ovary, and lymph node. Hematoxylin–eosin staining (HE staining) results of various tissues were included for comparison (column 1). Nuclei were visualized by Hoechst
staining (blue color in column 2). αA-crystallin stained in green was derived from FITC (column 3). Merge showed combination of Hoechst in blue and αA-crystallin in green
(column 4). Mouse lens section from embryonic day 11.5 was stained as positive control for αA-crystallin expression. Primary antibody was replaced by normal IgG in negative
control (last row). Note that normal human pancreas displays moderate level of αA-crystallin signal. Liver also displays αA-crystallin signal but the intensity is less (see B for other
tissues). Scale bar: 200 µm. (B) Quantiﬁcation of ﬂuorescence intensity. The mean intensity of ﬂuorescence was measured by Carl Zeiss Laser Scanning System LSM 510.
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nuclear extract prepared from either parentMiaPaCa cells (lane 13) or
vector pEGFP transfected MiaPaCa cells can bind to the wild type AP-1
oligo (lane 2) which was competed off by cold wild type oligo (lane 3)but much less by the mutated oligo (lane 4). The nuclear extracts pre-
cleared by antibodies against c-Jun (lane 5), c-Fos (lane 6) or both
antibodies (lane 7) lost most of the AP-1 activity so that the formed
AP-1 complex was either lost or appeared very weak. In contrast, the
Fig. 2.Western blot analysis of αA- and αB-crystallins in 11 tissues from normal adult
mouse (4 weeks). Various tissues were dissected and total proteins were extracted
from the 11 tissues indicated. For the lens sample, 0.5 μg of total protein was used for
Western blot analysis. For other samples, 100 μg of total protein was used. The blot was
probed with speciﬁc antibodies against αA-crystallin, αB-crystallin antibody, β-tubulin
or β-Actin at a dilution of 1:1000 for the primary antibody and at a dilution of 1:1500 for
the secondary antibody. Note that the mouse pancreas expresses a distinct level of αA-
crystallin but only a trace of αB-crystallin. Both β-actin and β-tubulin are absent in lane
1 (lens) and lane 2 (heart) due to limited sample loaded (only 0.5 μg lens protein in lane
1) or due to tissue characteristics (lacking β-actin and β-tubulin).
Fig. 3. Expression of αA-crystallin in human pancreatic cancer tissues. (A) Immunoh
immunohistochemistry results of αA-crystallin in two human normal pancreas samples we
cancerous pancreatic sections were included for comparison (column 1). Nuclei were visualize
fromFITC (column3).Merge showedcombination ofHoechst inblue andαA-crystallin ingreen
αA-crystallin expression. Primary antibodywas replaced by normal IgG in negative control (las
level ofαA-crystallin signal, and normal human pancreas sample B showsweaker signals than t
than that innormalhuman sampleAandalso slightlyweaker than that innormalhumansample
Carl Zeiss Laser Scanning System LSM 510. Each spot indicates the value of ﬂuorescence intens
intensity of one type of pancreatic cancer. Speciﬁcally, mean intensity of normal pancreas is 28
value more than 200); mean intensity of pancreatic duct adenocarcinoma is 9±16 (n=48);
of pancreatic islet adenocarcinoma is 56±69 (n=6) and mean intensity of pancreatic acinic c
625M. Deng et al. / Biochimica et Biophysica Acta 1802 (2010) 621–631nuclear extracts pre-cleared by normal IgG only slightly attenuated
the AP-1 complex (lane 8). These results suggest that the speciﬁc band
we detected between the nuclear extract from pEGFP-MiaPaCa cells
and the wild type oligo is the AP-1/DNA complex. Next, we compared
the AP-1 DNA binding activity in vector- and αA-crystallin-trans-
fected cells. As shown in lanes 9 and 11 of Fig. 5A, MiaPaCa cells
expressing αA-crystallin display signiﬁcant upregulation of AP-1
activity. Similar results were obtained with the lens epithelial cells,
αTN4-1 expressing either only EGFP or EGFP-αA-crystallin (Supple-
mentary Fig. 2). As a control for the speciﬁc binding to the AP-1 site,
we conducted the reaction using puriﬁed p53 protein and AP-1 oligo,
lane 12 of Fig. 5A clearly showed that p53 did not bind to AP-1 oligo.
To further conﬁrm that the transactivity of AP-1 was indeed
upregulated in MiaPaCa cells expressing αA-crystallin, we introduced
two reporter genes into the two types of stable transfectants: pEGFP-
MiaPaCa and pEGFP-αA-MiaPaCa. As shown in Fig. 5B, assayed with
either pJun-Luc (the luciferase gene was driven by the Jun promoter),
or pProlactin-1xAP-1-Luc (the luciferase gene was driven by a mini-
prolactin gene promoter containing a copy of AP-1 binding site), the
MiaPaCa cells expressingαA-crystallin showed statistically signiﬁcant
upregulation of luciferase activity, indicating the upregulation of AP-1
activity in αA-crystallin expression MiaPaCa cells (Fig. 5B). Thus,istochemistry results of αA-crystallin in human pancreatic cancer. As comparison,
re included. Hematoxylin–eosin staining (HE staining) results of two normal and two
d by Hoechst staining (blue color in column 2).αA-crystallin stained in green was derived
(column4).Mouse lens section fromembryonic day11.5was stainedas positive control for
t row). Scale bar: 200 µm. Note that normal human pancreas sample A displays moderate
he sample A. In the cancerous sample A, the level ofαA-crystallin signalwasmuchweaker
B. (B)Quantiﬁcationofﬂuorescence intensity. Theﬂuorescence intensitywasmeasuredby
ity from a single tissue sample. Each short solid line indicates mean value of ﬂuorescence
3±267 (n=11 among which 3 samples have a value less than 100 and 8 samples have a
mean intensity of pancreatic mucinous adenocarcinoma is 3±5 (n=3); mean intensity
ell carcinoma is 128±55 (n=3).
Fig. 4. Expression of αA-crystallin in pancreatic cancer cell line, MiaPaCa, upregulates
expression of c-Jun and c-Fos. The stable clones ofMiaPaCa cells expressing pEGFP, pEGFP-
HαA or pEGFP-HαB were grown to 95% conﬂuence in MEM with 10% FBS and 400 μg/ml
G418, and then harvested for extraction of total proteinswhichwere subjected toWestern
blot analysis for AP-1 components, c-Jun and c-Fos, in two different cellular fractions:
cytoplasmic andnuclear portions.Note thatMiaPaCa cells expressingαA-crystallin display
upregulated levels of c-Jun and c-Fos protein. In addition, the phospho-c-Jun levelwas also
enhanced in pEGFP-HαA-MiaPaCa cells.
626 M. Deng et al. / Biochimica et Biophysica Acta 1802 (2010) 621–631expression of αA-crystallin in pancreatic cancer cells positively regulates
AP-1 activity.
3.6. αA-crystallin positively regulates ERK2 MAPK
It has been shown that AP-1 expression and activity can be enhanced
by MAP kinases [44–48]. To explore how might αA-crystallin regulate
AP-1, we examined the possible modulation of ERK kinase activity by
αA-crystallin since ERK is a major MAP kinase regulating AP-1
components in both expression and activation [44–48]. As shown in
Fig. 6A, we found that Elk was dose-dependently phosphorylated by
ERK2 in vitro. Moreover, in the presence of αA-crystallin, phosphory-
lation of Elk by 0.1 or 1 ng ERK2was signiﬁcantly enhanced. Addition of
1 μg of αA-crystallin into the ERK2 kinase reaction with low level of
ERK2 (1 ng) enhanced more than 10-fold Elk phosphorylation, reﬂect-
ing the corresponding enhancement of ERK2 activity. Together, these
results reveal that αA-crystallin can positively regulate AP-1 activity
through modulation of ERK activity. To further conﬁrm that αA-
crystallin enhances ERK2 kinase activity, we analyzed the ERK1/2
expression and activity in vector- and αA-crystallin-transfected stable
lines of cells. As shown in Fig. 6C, both expression and activity of ERK2
were clearly upregulated inMiaPaCa cells expressingαA-crystallin than
vector-transfected cells.
3.7. αA-crystallin regulates TGFβ signaling pathway
To determine whether αA-crystallin actively regulates TGFβ
signaling pathway which plays a key role in pancreatic carcinogenesis
[20], we ﬁrst examined expression of several genes in the TGFβ
signaling pathway at the mRNA level. As shown in Fig. 7, TGFβ was
increased about 2-fold when αA-crystallin was overexpressed in
MiaPaCa (Fig. 7A and B, similar result was observed in αA-crystallin-
transfected Capan-1 cells, data not shown). For the receptor, TGFβ
receptors 1 and 2 are not detected and TGFβ receptor 3 displayed little
change in the three types of cells (Fig. 7A and C). To further conﬁrm
the modulation of TGFβ signaling pathway by αA-crystallin, we
examined the protein expression levels of TGFβ and the downstream
smads, as well as the phosphorylation status of the smads. As shownin Fig. 8, Western blot analysis revealed that TGFβwas also upregulated
at the protein level. In addition, expression and phosphorylation of
Smad 3 and Smad 5 were signiﬁcantly upregulated. Thus, αA-crystallin
actively enhances TGFβ signaling pathway.
3.8. Retardation of cell migration in αA-crystallin-overexpressed cells
To explore how αA-crystallin may regulate carcinogenesis, we
conducted wound healing assay using the established stable cell lines:
pEGFP-MiaPaCa, pEGFP-αA-MiaPaCa and pEGFP-αB-MiaPaCa. When
these cells with similar expression levels were selected to conduct
wound healing assays (Fig. 9), it was found that MiaPaCa cells
expressing αA-crystallin displayed statistically signiﬁcant retardation
in cell migration. In contrast, the same cells expressing either the
vector or αB-crystallin did not show such effect. Thus, αA-crystallin
retards migration of pancreatic cancer cells, which is consistent with
its downregulation in various types of pancreatic carcinoma (Fig. 3).
4. Discussion
In the present study, we have demonstrated the following: 1) αA-
crystallin is expressed at moderate level in pancreas from human and
mouse, a non-ocular tissue previously not documented; 2) αA-
crystallin is signiﬁcantly downregulated in the pancreatic tumors than
in the normal human pancreas; 3) expression of αA-crystallin in
pancreatic carcinoma cells induces signiﬁcant upregulation of the AP-
1 components and activity, 4) αA-crystallin can enhance activity of
ERK2 MAP kinase, through which it can regulate AP-1 expression and
activity; 5) expression of αA-crystallin in pancreatic carcinoma cells
signiﬁcantly enhanced the TGFβ signaling pathways; and 6) expres-
sion of αA-crystallin in pancreatic cells led to obvious retardation of
the cell migration. Together, our results suggest that αA-crystallin
appears to negatively regulate pancreatic carcinogenesis, which is in
contrast to the function of αB-crystallin in breast cancer.
4.1. αA-crystallin is expressed in normal pancreas besides other
non-lenticular tissues
αA-crystallin is ﬁrst known as a lens structural protein [10,11]. It
shares about 60% identity in amino acid sequence with αB-crystallin,
another lens structure protein [10,11]. Several lines of evidence have
shown that although the two genes encoding αA- and αB-crystallins
may arise from gene duplication, they have diverged signiﬁcantly.
First, during murine development, the initial turning on of the two
genes occurs at different time. While αB mRNA is ﬁrst becoming
detectable at E9.5, expression ofαAmRNA appears at E10.5 [10]. Such
differential turning on time reﬂects the different control mechanisms
in the promoters of the two α-crystallin genes. Second, the two genes
display distinct tissue-speciﬁc expression patterns. WhileαA is highly
restricted to lens during mouse embryonic developmental process,
αB-crystallin is expressed in the developing heart, nasal epithelium,
and retinal pigment epithelium [10]. In the adult vertebrates,
although both αA and αB are abundantly expressed in the lens,
they display signiﬁcant difference in non-lenticular tissue expres-
sions. αB is strongly expressed in the heart, skeletal muscle, kidney
and brain [11–13]. In contrast,αA is reported to be expressed at a very
low level in some non-lenticular tissues including the spleen, thymus,
heart, brain and liver [16,34]. In the present study, our results not only
conﬁrm the presence of a low level of αA-crystallin in the kidney and
liver, but also reveal a moderate level of αA-crystallin expression in a
novel non-lenticular tissue, the normal human pancreas. Among the
11 normal human pancreas samples examined, 7 samples display
consistently moderate level of αA-crystallin expression and the
remaining 4 samples also showed a low level of αA-crystallin
expression (Fig. 1). The pancreatic distribution of αA-crystallin is
further conﬁrmed from analysis of mouse tissue samples (Fig. 2).
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abundance αA-crystallin in both lens and non-lenticular tissues (ng
αA-crystallin/per mg total protein in organ). These authors found
that in the adult rat (8–16 weeks), the lens contains 244 μg αA-Fig. 5. Expression ofαA-crystallin in pancreatic cancer cell line, MiaPaCa, upregulates AP-1 DN
the existence of AP-1 DNA binding activity in parent MiaPaCa cell nuclear extract (lane 13),
MiaPaCa cell nuclear extracts expressing αA-crystallin (lane 11) or αB-crystallin (lane 10)
labeled oligos containing wild type AP-1 binding site (up panel of A left part) under various c
AP-1 oligo. Lane 2, gel mobility shifting assay with labeled wild type AP-1 oligo and pEGFP-M
labeled wild type AP-1 oligos was added into the reaction. Lane 4, the same assay as in lan
(bottom panel of Fig. 5A left part). Lane 5, gel mobility shifting assay with labeledwild type A
gel mobility shifting assay with labeled wild type AP-1 oligo and pEGFP-MiaPaCa nuclear ex
wild type AP-1 oligo and pEGFP-MiaPaCa nuclear extract pre-cleared by anti-c-Jun antibody
oligo and pEGFP-MiaPaCa nuclear extract pre-cleared by normal IgG. Lane 9, the same assay
from the pEGFP-HαB-MiaPaCa cells. Lane 11, the same assay as in lane 2 except that the n
speciﬁcity), the same assay as in lane 2 except that the nuclear extract was replaced with i
assays to demonstrate that the AP-1 transactivity in pEGFP-HαA-MiaPaCa cells was signiﬁca
mini-prolactin gene promoter without enhancer (pProlactin-Luc), or with 1 copy of AP-1 bin
with a reference plasmid were separately transfected into pEGFP-MiaPaCa cells, pEGFP-Hα
harvested for the assaying of luciferase activity. After calibration with the luciferase activity f
Note that as assayed by both constructs, pProlactin-1xAP-1-Luc and pJun-Luc, the AP-1 acti
cells (pb0.005 for pJun-Luc construct, and pb0.05 for pProlactin-1xAP-1-Luc construct). In
pEGFP-HαB-MiaPaCa cells (pN0.05 in both cases).crystallin/per mg total lens protein, and the spleen contains 16.6 ng
αA-crystallin/per mg total spleen protein, so the relative abundance
of lens αA-crystallin is about 14,698-fold. Using confocal ﬂuores-
cence microscopy, we quantitated the relative abundance of αA-A binding activity (A) and transactivity (B). A. Gel mobility shifting assay demonstrates
pEGFP-MiaPaCa cell nuclear extracts (lanes 2 to 9), which was much lower than that in
. Nuclear extracts prepared from three types of cells were incubated with γ-32P-ATP-
onditions shown in the ﬁgure. Lane 1, gel mobility shifting assay with labeled wild type
iaPaCa nuclear extract. Lane 3, the same assay as in lane 2 except that 50-fold of non-
e 3 except that the non-labeled competing oligo contains a mutated AP-1 binding site
P-1 oligo and pEGFP-MiaPaCa nuclear extract pre-cleared by anti-c-Jun antibody. Lane 6,
tract pre-cleared by anti-c-Fos antibody. Lane 7, gel mobility shifting assay with labeled
and anti-c-Fos antibody. Lane 8, gel mobility shifting assay with labeled wild type AP-1
as in lane 2. Lane 10, the same assay as in lane 2 except that the nuclear extracts were
uclear extracts were from the pEGFP-HαA-MiaPaCa cells. Lane 12 (mock for AP-1 site
n vitro synthesized p53 protein. Note that p53 does not bind to AP-1 site. B. Luciferase
ntly higher than that in pEGFP-MiaPaCa cells. The luciferase reporter gene driven by a
ding site (pProlactin-1xAP-1-Luc), or driven by the c-Jun promoter (pJun-Luc), together
A-MiaPaCa cells, or pEGFP-HαB-MiaPaCa cells. After 48 h, the transfected cells were
rom the reference plasmid, the transactivity of AP-1 in each type of cells was presented.
vity in pEGFP-MiaPaCa cells were signiﬁcantly lower than that in pEGFP-HαA-MiaPaCa
contrast, the AP-1 activity in pEGFP-MiaPaCa cells is only slightly lower than that in
Fig. 6. αA-crystallin enhances MAPK (ERK2) activity in the in vitro kinase assay. A. The
substrate of Elk-1 protein was phosphorylated by ERK2 kinase in the in vitro assay in the
presenceofATP.PhosphorylationofElkwasdetectedbyWesternblot analysis asdescribed
above. Results of two different exposures were shown. The kinase reaction with GSK3β
was included as control for ERK2. B. Quantitative results of the Elk phosphorylation under
different conditions. The relative pixel of each band was quantitated using the software
from Silk Scientiﬁc Inc. Note that at the concentration of 0.1 and 1 ng ERK2 kinase
conditions, addition of 1 or 10 μg ofαA-crystallin signiﬁcantly enhances the ERK2 activity
as reﬂected by the differential intensity of Elk phosphorylation. C.Western blot analysis of
expression and activities of ERK1/2 in vector- or αA-transfected MiaPaCa cells. Western
blot analysiswas conducted as described in Fig. 2. Note that both expression and activity of
ERK2 was upregulated in MiaPaCa cells expressing αA-crystallin than vector-transfected
cells.
628 M. Deng et al. / Biochimica et Biophysica Acta 1802 (2010) 621–631crystallin in the developingmouse lens and the pancreatic tissue, and
found that the corresponding values are 807±48 and 283±67,
respectively. Therefore, the human adult pancreatic signal of αA-
crystallin is about 1/3 of the developing mouse eye lens (Fig. 1). In
mouse tissue, we estimate thatαA-crystallin in lens is about 500-fold
higher than that in the pancreas (see Fig. 2, 200-fold difference in
sample load×2.5-fold difference in αA-crystallin band in the lens
versus in the pancreas). Together, our results demonstrate that the
pancreas expresses a moderate level of αA-crystallin.Fig. 7.αA-crystallin modulates expression of TGFβ as demonstrated by RT-PCR analysis.
A. RT-PCR. Total cellular RNAs were extracted from vector-, HαA- or HαB-crystallin-
transfected cells, then were used for RT-PCR assays as described in the Materials and
methods. B. Quantitation of TGFβ mRNA level in vector-, HαA- or HαB-crystallin-
transfected MiaPaCa cells. C. Quantitation of TGFβ receptor 3 mRNA level in vector-,
αA- or αB-crystallin-transfected MiaPaCa cells. Note that αA-crystallin enhances
expression of TGFβ mRNA but has little effect on TGF receptors.4.2. αA-crystallin is implicated in carcinogenesis
It is well established that small heat shock proteins are
implicated in carcinogenesis [8]. One of the most studied membersis Hsp27, which is involved in carcinogenesis of many different
types of tissues [35,49–57]. Another member of the HSP family
implicated in carcinogenesis is αB-crystallin. Iwaki and Tateishi [58]
ﬁrst demonstrated the existence of αB-crystallin in hamartomas of
tuberous sclerosis. Then, it was found that concentrations of αB-
crystallin in prostatic carcinoma tissues were signiﬁcantly higher
than in benign prostatic hyperplasia [59]. In breast cancer cells, αB-
crystallin was found expressing constitutively in certain breast
carcinoma cell lines, and increased intensity of αB-crystallin
expression was correlated with shorter survival [33]. Moreover,
expression of αB-crystallin results in transformation of immortal-
ized human mammary epithelial cells, induction of EGF- and
anchorage-independent growth, and enhancement of cell migration
Fig. 8. αA-crystallin modulates protein expression of TGFβ and Smad3/5, as well as the
phosphorylation status of Smad3/5. Western blot analysis was conducted as described
in Fig. 2. Note that αA-crystallin enhances expression of TGFβ, Smad3 and Smad5.
Moreover, αA-crystallin upregulates the phosphorylation status of Smad3/5.
629M. Deng et al. / Biochimica et Biophysica Acta 1802 (2010) 621–631and invasion [15]. Thus, αB-crystallin is considered as a novel
oncoprotein [15].
Both αA- and αB-crystallins belong to the heat shock protein
(Hsp) family [2]. Whether αA-crystallin is also in implicated inFig. 9. Demonstration that the pancreatic cancer cell line, MiaPaCa, expressing the exogenous
MiaPaCa, pEGFP-HαA-MiaPaCa or pEGFP-HαB-MiaPaCa cells were seeded in 6-well plates a
blue pipette tip to simulate the wound healing in each well. After PBS washing for 2 times,
healing process was recorded daily using the Leica Inverted Phase Contrast Fluorescence Mi
healing process than pEGFP-MiaPaCa and pEGFP-HαB-MiaPaCa cells, suggesting both slowecarcinogenesis remains to be explored. ComparedwithαB-crystallin,
the limited distribution ofαA-crystallin in non-lenticular tissuesmay
restrict its function in carcinogenesis [10–14]. Nevertheless, several
recent studies suggest that αA-crystallin may be also implicated in
tumor development. First, in 4 cases of human sebaceous carcinoma
of the eyelid examined, both αA-crystallin and αB-crystallin were
found highly expressed [60]. Second, in the retinocytoma, αA-
crystallin was expressed in the cytoplasm of all tumor cells and the
apoptotic index was signiﬁcantly higher in those cases with weak
signal of αA-crystallin than in those that were strongly positive [61].
These results suggest that αA-crystallin, acting like αB-crystallin,
seems to promote carcinogenesis. On the other hand, a recent study
revealed that in 6 cases of retinoblastoma, preoperative chemother-
apy induced strong expression of only Hsp27 and αB-crystallin but
notαA-crystallin [62]. Moreover, the viable tumor cells that survived
contained high levels of Hsp27 and αB-crystallin but not αA-
crystallin. Therefore, these results indicate that αA-crystallin does
not seem to act the same way as Hsp27 and αB-crystallin do in
promoting carcinogenesis. Our present ﬁnding that in 60 different
cases of pancreatic carcinoma, the expression level of αA-crystallin
was consistently downregulated than that in 11 normal human
pancreas samples also supports the negative regulation of carcino-
genesis byαA-crystallin. In addition, our results also suggest thatαA-
crystallin may be used as one of the biomarkers for pancreatic cancer
diagnosis.HαA-crystallin display retarded cell migration. The stable transfected cell lines, pEGFP-
nd grown until 95% conﬂuent. Then, two straight scratches were made by using a 1 ml
new DMEM medium was added for a continuous growth of another 48 h. The wound
croscopy with a 10× objective. Note that the pEGFP-HαA-MiaPaCa cells display slower
r cell migration and proliferation of pEGFP-HαA-MiaPaCa cells.
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tumors
Pancreatic malignancy develops from intraepithelial neoplasia
(PanIN), progressing through PanIN-1a, PanIN-1b, PanIN-2, and
PanIN-3 to ductal adenocarcinomas (PDAC) [63,64]. During this process,
key oncogenes and tumor suppressors such as Ki-RAS, p16INK4a, P53,
DPC/SMAD4, and BRCA2 play very important roles [20–22,65–68]. The
carcinogenesis signals are mediated by major signaling pathways
including MAPK pathways, sonic hedgehog and notch signaling path-
ways, and also TGFβ signaling pathways [20–22,65–68]. In the present
study, we present several lines of evidence to show that αA-crystallin
seems to negatively regulate development of pancreatic tumors. First,
we demonstrate that compared with the physiological level in normal
human pancreas, αA-crystallin is signiﬁcantly downregulated in 60
cases of pancreatic carcinomas of various types. Second, we show that
pancreatic cancer cells expressing αA-crystallin display retarded cell
migration. Finally, we show that pancreatic cancer cells expressing αA-
crystallin have enhanced expression levels of c-Jun and c-Fos, increased
phosphorylation of c-Jun oncoprotein, and elevated level of AP-1
activities in both DNA binding and transactivation, which is derived
from enhanced activity of the ERK2 kinase promoted by αA-crystallin
(Fig. 6). As a result, αA-crystallin positively regulates TGFβ signaling
pathway (Figs. 7 and 8) through MAP kinase, and thus negatively
regulate development of pancreatic malignancy.
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